iZafe Group AB announced that the company has successfully completed all necessary technical integrations and adaptations to launch its medication robot, Dosell, in the Dutch market. These adaptations have included both technical adjustments in the Dosell device and platform, as well as extensive developments and customers from partner. As a significant step forward, iZafe Group will now deliver 50 Dosell units to test the new customer journey in practice for one month.

This phase of the pilot program will contribute to ensuring a smooth launch and customer experience. Following successful testing, the remaining 1,000 units will be delivered gradually throughout the rest of the year, according to the previously communicated plan.